novartis hits acquisition trail
swiss drugmaker novartis euros purchases sandoz unit generic drug producer
novartis forecast germany hexal acquired hexal affiliate eon labs offered remaining shares novartis savings acquisitions novartis shares rose swiss francs trading
novartis sandoz overtake israel teva pharmaceuticals maker generics newly merged producer estimated novartis merge departments adding
outlook sandoz partially compensate reductions generic drugs chemically identical expensive branded rivals producers sandoz copy branded patent protection expires cheaply
generic drugmakers worldwide predicted consolidation fragmented initially convinced expensive acquisition birgit kuhlhoff sal oppenheim investment bank reuters strange acquisitions markets suffered pressure
